Company Filing History:
Years Active: 1993
Title: The Innovations of Keith M Gewain
Introduction
Keith M Gewain is a notable inventor based in Middlesex, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of avermectin biosynthesis. His work has implications for agricultural and pharmaceutical applications.
Latest Patents
Keith M Gewain holds a patent for "Cloning genes from Streptomyces avermitilis for avermectin biosynthesis." This patent includes plasmids containing DNA isolated from Streptomyces avermitilis, which is essential for preparing avermectin compounds. The disclosed plasmids, identified as pAT1, pVE650, pVE855, pVE859, pVE1446, pVE923, and pVE924, contain the genetic information necessary for the biosynthesis of avermectins. The patent also outlines methods for isolating these plasmids and manipulating them to alter the formation of the avermectin compound. He has 1 patent to his name.
Career Highlights
Keith Gewain is currently employed at Merck & Co., Inc., where he continues to advance his research in biotechnology. His work at Merck has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Douglas J MacNeil and Tanya MacNeil. Their collaborative efforts contribute to the innovative research environment at Merck.
Conclusion
Keith M Gewain's contributions to biotechnology, particularly through his patent on avermectin biosynthesis, highlight his role as an influential inventor in the field. His work continues to impact agricultural and pharmaceutical industries significantly.